|
?:authorAffiliation
|
-
[\'Julius Clinical, Zeist, the Netherlands. timo.brakenhoff@juliusclinical.com.\', \'Julius Clinical, Zeist, the Netherlands.\', \'Ava AG, Zurich, Switzerland.\', \'Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.\', \'Roche Diagnostics Nederland BV, Almere, the Netherlands.\', \'Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.\', \'Optentia Research Program, North-West University, Potchefstroom, South Africa.\', \'Vive, Aarhus, Denmark.\', \'Sanquin, Amsterdam, the Netherlands.\', \'Labormedizinisches zentrum Dr. Risch, Vaduz, Liechtenstein.\', \'Faculty of Medical Sciences, Private Universität im Fürstentum Liechtenstein, Triesen, Liechtenstein.\', \'Center of Laboratory Medicine, University Institute of Clinical Chemistry, University of Bern, Bern, Switzerland.\', \'Data Sciences Institute, Takeda Pharmaceuticals U.S.A. Inc., Cambridge, MA, USA.\', \'National Institute for Health Research Maudsley Biomedical Research Centre, King\'s College London, London, UK.\', \'Institute of Health Informatics, University College London, London, UK.\', \'South London and Maudsley NHS Foundation Trust, London, UK.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}